The protein encoded by this gene is the beta component of fibrinogen, a blood-borne glycoprotein composed of three pairs of nonidentical polypeptide chains. Following vascular injury, fibrinogen is cleaved by thrombin to form fibrin which is the most abundant component of blood clots. In addition, various cleavage products of fibrinogen and fibrin regulate cell adhesion and spreading, display vasoconstrictor and chemotactic activities, and are mitogens for several cell types. Mutations in this gene lead to several disorders, including afibrinogenemia, dysfibrinogenemia, hypodysfibrinogenemia and thrombotic tendency.
Vasse M, Paysant J, Soria J, et al. (1997). "Regulation of fibrinogen biosynthesis by cytokines, consequences on the vascular risk.". Haemostasis. 26 Suppl 4: 331–9. PMID8979138. doi:10.1159/000217313.
Scott EM, Ariëns RA, Grant PJ (2005). "Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease.". Arterioscler. Thromb. Vasc. Biol. 24 (9): 1558–66. PMID15217804. doi:10.1161/01.ATV.0000136649.83297.bf.
Chen XC, Xu MT, Zhou W, et al. (2007). "A meta-analysis of relationship between beta-fibrinogen gene -148C/T polymorphism and susceptibility to cerebral infarction in Han Chinese.". Chin. Med. J. 120 (13): 1198–202. PMID17637253.
Tarakhovskiĭ IuS; Galushchenko IV; Boroviagin VL; et al. (1979). "[Temperature-dependent changes in the profile of the sarcoplasmic reticulum membrane hydrophobic zones]". Biokhimiia. 44 (5): 897–902. PMID156564.
Watt KW, Takagi T, Doolittle RF (1979). "Amino acid sequence of the beta chain of human fibrinogen.". Biochemistry. 18 (1): 68–76. PMID420779. doi:10.1021/bi00568a011.
Gårdlund B, Hessel B, Marguerie G, et al. (1977). "Primary structure of human fibrinogen. Characterization of disulfide-containing cyanogen-bromide fragments.". Eur. J. Biochem. 77 (3): 595–610. PMID891553. doi:10.1111/j.1432-1033.1977.tb11704.x.